ChIP-seq of PPARGC1A in oesophageal adenocarcinoma OE19 cells treated with lapatinib
Ontology highlight
ABSTRACT: ChIP-seq for PPARGC1A was performed in OE19 cells to identify genomic binding sites. Cells were treated with 500 nM lapatinib for 48 hours.
INSTRUMENT(S): Illumina HiSeq 4000
ORGANISM(S): Homo sapiens
SUBMITTER: Sam Ogden
PROVIDER: E-MTAB-11300 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA